Brazil · Business
Key Facts
—Extrajudicial recovery filed: Oncoclínicas submitted its plan on 14 July 2026 to renegotiate roughly R$5.1 billion (US$1.01 billion) in financial debt.
—Goldman Sachs exit: The US bank sold its stake after 11 years, stepping away as the company entered formal creditor negotiations.
—Patient care unaffected: Consultations, chemotherapy, and radiotherapy continue normally; the process targets financial creditors, not clinical operations.









